DRUG SUPPLIED DOSE COMMENTS
GLYCOPYRROLATE (Paeds)


Mechanism of action:

Anticholinergic 



Ref: 44, 248, 640, 641, 642


Last update: 2022-07-03		 Injection: 0.2 mg/mL; 1 mL amps
Oral suspension (BCCH): 0.5 mg/mL
 Control of secretions/respiratory antisecretory:
Children:
PO: 40-100 mcg/kg/dose TID to QID Max.: 2 mg/dose)
IV/SC: 4-10 mcg/kg/dose IV Q4-8H. Max 0.2 mg/dose, 0.8 mg/24h

Adult:
PO/SL/SC: 200-400 mcg/dose Q4-8H. Max: 4 doses/24h
Nausea, constipation, urinary retention, dry mouth, blurred vision, cardiac dysrhythmia.

Use with caution in hepatic and renal disease, ulcerative colitis, asthma, glaucoma, ileus or urinary retention

Injection form may be used orally


Standard Prescription:

glycopyrrolate__mcg IV{PO} Q   H (__mcg/kg/dose)